首页> 美国卫生研究院文献>PLoS Pathogens >Allele-Specific Induction of IL-1β Expression by C/EBPβ and PU.1 Contributes to Increased Tuberculosis Susceptibility
【2h】

Allele-Specific Induction of IL-1β Expression by C/EBPβ and PU.1 Contributes to Increased Tuberculosis Susceptibility

机译:C /EBPβ和PU.1等位基因特异性诱导IL-1β表达有助于增加结核病易感性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mycobacterium tuberculosis infection is associated with a spectrum of clinical outcomes, from long-term latent infection to different manifestations of progressive disease. Pro-inflammatory pathways, such as those controlled by IL-1β, have the contrasting potential both to prevent disease by restricting bacterial replication, and to promote disease by inflicting tissue damage. Thus, the ultimate contribution of individual inflammatory pathways to the outcome of M. tuberculosis infection remains ambiguous. In this study, we identified a naturally-occurring polymorphism in the human IL1B promoter region, which alters the association of the C/EBPβ and PU.1 transcription factors and controls Mtb-induced IL-1β production. The high-IL-1β expressing genotype was associated with the development of active tuberculosis, the severity of pulmonary disease and poor treatment outcome in TB patients. Higher IL-1β expression did not suppress the activity of IFN-γ-producing T cells, but instead correlated with neutrophil accumulation in the lung. These observations support a specific role for IL-1β and granulocytic inflammation as a driver of TB disease progression in humans, and suggest novel strategies for the prevention and treatment of tuberculosis.
机译:从长期潜伏感染到进行性疾病的不同表现,结核分枝杆菌感染与一系列临床结果有关。促炎途径,例如受IL-1β控制的途径,具有相反的潜力,既可以通过限制细菌复制来预防疾病,又可以通过破坏组织来促进疾病。因此,个体炎症途径对结核分枝杆菌感染的最终贡献仍然是模棱两可的。在这项研究中,我们确定了人类IL1B启动子区域的自然多态性,该多态性改变了C /EBPβ和PU.1转录因子的关联并控制了Mtb诱导的IL-1β的产生。高表达IL-1β的基因型与活动性结核病的发展,肺部疾病的严重程度以及结核病患者的治疗结果差有关。 IL-1β的较高表达不会抑制产生IFN-γ的T细胞的活性,但与肺中的中性粒细胞积累有关。这些观察结果支持IL-1β和粒细胞炎症作为人类结核病进展的驱动因素的特定作用,并提出了预防和治疗结核病的新策略。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号